No definition available.
Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)
C3_PAROTIDGLAND_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
336 |
4. Check minimum number of eventsNone |
336 |
5. Include endpointsNone |
336 |
6. Filter based on genotype QC (FinnGen only) |
336 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 336 | 155 | 181 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.08 |
| Median age at first event (years) | 61.79 | 58.74 | 64.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 249
- Matched controls
- 2491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
169.9
143
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
199.3
159.8
154
20
ELB50
NOMESCO Finland
Total parotidectomy
1545.0
106.5
96
*
ELB40
NOMESCO Finland
Partial parotidectomy
180.9
99.8
99
9
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
63.3
58
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
32.1
59.9
80
36
130
Kela drug reimbursment
Malignant tumour
+∞
54.2
50
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
49.7
46
*
8550/3-C07.9
ICD-O-3
Acinar cell carcinoma of parotid gland
+∞
43.0
40
*
C07.71
ICD-10 Finland
Malignant tumor in the deep part of the parotid gland
+∞
40.8
38
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
237.0
40.1
40
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
37.4
35
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.6
34.4
83
137
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
135.1
33.6
35
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
30.9
29
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.3
30.0
116
350
8430/3-C07.9
ICD-O-3
Mucoepidermoid carcinoma of parotid gland
+∞
29.8
28
*
WF002
NOMESCO Finland
Radical radiotherapy
163.3
28.3
29
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
15.4
28.1
47
37
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
17.7
27.2
43
29
WX408
NOMESCO Finland
General anesthesy, balanced
4.7
25.9
113
374
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
25.4
24
*
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
25.4
24
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.2
25.2
49
53
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
24.4
23
*
H02AB02
ATC
dexamethasone; systemic
35.1
24.4
31
10
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
+∞
23.3
22
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.1
22.3
31
14
8070/3-C07.9
ICD-O-3
Squamous cell carcinoma, NOS, of parotid gland
+∞
22.2
21
*
8500/3-C07.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of parotid gland
+∞
21.1
20
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
21.1
20
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
21.1
20
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
21.1
20
*
C07
ICD-10 Finland
Malignant neoplasm of parotid gland
+∞
20.1
19
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
114.2
19.9
21
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
19.0
18
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
19.0
18
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
17.9
17
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
17.9
17
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
45.7
17.6
21
5
G51.0
ICD-10 Finland
Bell palsy
13.5
17.4
30
25
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
+∞
16.9
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.9
16
*
8200/3-C07.9
ICD-O-3
Adenoid cystic carcinoma of parotid gland
+∞
16.9
16
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
96.7
16.8
18
*
JN4BD
NOMESCO Finland
Extensive body CT
8.1
16.6
38
54
R4190
NOMESCO Finland
Nutritional therapy
26.6
16.3
22
9
A04AA01
ATC
ondansetron; systemic, rectal
16.5
15.2
24
16
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
85.3
14.7
16
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.7
14
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.7
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.7
14
*
WX402
NOMESCO Finland
General anaesthesia
4.6
14.7
54
140
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
15.7
14.4
23
16
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
79.6
13.7
15
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
79.6
13.7
15
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.7
13
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
147.7
13.6
14
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
13.2
13.4
23
19
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
12.6
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
12.6
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
11.9
12.3
22
20
L03AA02
ATC
filgrastim; parenteral
68.3
11.7
13
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.2
11.7
28
43
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.5
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
8140/3-C07.9
ICD-O-3
Adenocarcinoma, NOS, of parotid gland
+∞
11.5
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.5
11
*
8562/3-C07.9
ICD-O-3
Epithelial-myoepithelial carcinoma of parotid gland
+∞
11.5
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
125.6
11.5
12
*
XW000
NOMESCO Finland
Bone marrow biopsy
9.2
10.8
22
26
A07AA02
ATC
nystatin; oral
5.6
10.6
31
62
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
114.6
10.5
11
*
H02.2
ICD-10 Finland
Lagophthalmos
114.6
10.5
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
114.6
10.5
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
2.5
10.5
108
577
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
10.5
10
*
WX110
NOMESCO Finland
Local anesthesy
2.5
10.4
173
1186
Z51.5
ICD-10 Finland
Palliative care
10.7
10.2
19
19
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
41.9
10.1
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
10.0
118
670
S04
ICPC
Lump/swelling localized
4.3
10.0
37
96
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
9.5
112
632
AAH50
NOMESCO Finland
Cranial nerve anastomosis
103.8
9.5
10
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
103.8
9.5
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
103.8
9.5
10
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
22.7
9.4
13
6
L02BB03
ATC
bicalutamide; oral
+∞
9.4
9
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
9.4
9
*
8010/3-C07.9
ICD-O-3
Carcinoma, NOS, of parotid gland
+∞
9.4
9
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
9.4
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
9.4
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.4
9
*
9591/3-C07.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of parotid gland
+∞
9.4
9
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
9.4
9
*
UDC00
NOMESCO Finland
Ear microscopy
4.4
9.4
34
86
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.7
9.3
23
37
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
51.9
8.7
10
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.8
8.7
24
45
ED1AA
NOMESCO Finland
Mandipular X-ray examination
28.6
8.6
11
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
93.1
8.5
9
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
93.1
8.5
9
*
N02AA05
ATC
oxycodone; systemic
3.2
8.4
46
163
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
+∞
8.4
8
*
8941/3-C07.9
ICD-O-3
Carcinoma ex pleomorphic adenoma of parotid gland
+∞
8.4
8
*
EBA10
NOMESCO Finland
Surgical removal of tooth
3.7
8.2
36
109
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.3
8.2
42
144
ZXA00
NOMESCO Finland
Right side
2.4
7.9
83
436
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
15.7
7.8
12
8
4405
FHL
Partial removal of the parotid gland
46.5
7.8
9
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
8.5
7.7
16
20
WZC30
NOMESCO Finland
Teaching
3.5
7.7
36
115
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
19.1
7.7
11
6
ZXA05
NOMESCO Finland
Left side
2.4
7.7
78
402
K05.30
ICD-10 Finland
Periodontitis complex
3.1
7.5
42
152
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
82.4
7.5
8
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
82.4
7.5
8
*
S18
ICPC
Laceration/cut
2.1
7.4
111
681
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
8502/3-C07.9
ICD-O-3
Secretory carcinoma of parotid gland
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
ELB60
NOMESCO Finland
Radical parotidectomy sacrificing the facial nerve
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
8147/3-C07.9
ICD-O-3
Basal cell adenocarcinoma of parotid gland
+∞
7.3
7
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
+∞
7.3
7
*
4404
FHL
Complete removal of the parotid gland
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
7.3
7
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.0
6.9
21
45
H02.1
ICD-10 Finland
Ectropion of eyelid
17.3
6.8
10
6
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
41.2
6.8
8
*
ZZR00
NOMESCO Finland
Flap of skin
23.2
6.7
9
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
12.7
6.6
11
9
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
12.7
6.6
11
9
H60.4
ICD-10 Finland
Cholesteatoma of external ear
71.6
6.5
7
*
UJC01
NOMESCO Finland
Scopy of lower throat
14.8
6.4
10
7
DFF00
NOMESCO Finland
Pure tone audiometry
3.3
6.4
31
102
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
6.4
67
348
L02AE02
ATC
leuprorelin; implant, parenteral
18.6
6.3
9
5
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
6.3
6
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
6.3
6
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
27.4
6.3
8
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
27.4
6.3
8
*
JN4AD
NOMESCO Finland
Body CT examination
5.8
6.1
16
29
K11.2
ICD-10 Finland
Sialoadenitis
6.3
6.1
15
25
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
10.4
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
133
63
34.29
187.75
1.7
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
107
33
47.11
173.08
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
193
755
4.66
43.38
2.9
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
77
197
4.77
28.72
1.4
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
225
1343
3.04
20.63
12.2
6.3
e9/l
3.7
4.3
4.10
200
1174
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
63
194
3.77
17.88
1.8
1.8
g/l
0.2
0.2
3.86
63
170
(3044640) Blood type and Crossmatch panel - Blood
136
702
2.57
15.28
2.5
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
540
2.68
15.27
2.5
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
76
298
3.00
14.46
2.3
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
116
581
2.52
13.62
4.1
3.2
%
87.3
88.0
0.10
116
562
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
66
247
3.08
13.57
6.6
2.9
u/l
229.9
236.4
0.28
66
232
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
177
1080
2.35
13.25
3.8
3.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
112
559
2.51
13.18
10.2
4.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
144
805
2.38
13.18
6.0
2.1
mmol/l
2.3
2.4
0.30
135
673
(3001604) Monocytes [#/volume] in Blood
190
1212
2.31
12.59
6.4
5.0
e9/l
0.6
0.6
1.94
166
1041
(3013115) Eosinophils [#/volume] in Blood
193
1251
2.28
12.16
6.7
5.3
e9/l
0.2
0.2
4.39
172
1099
(3006504) Eosinophils/100 leukocytes in Blood
179
1130
2.25
11.96
6.7
5.2
%
2.8
3.0
0.80
169
1038
(3006315) Basophils [#/volume] in Blood
189
1220
2.26
11.96
6.5
5.0
e9/l
0.0
0.0
1.69
166
1049
(3019198) Lymphocytes [#/volume] in Blood
191
1240
2.25
11.89
6.6
5.1
e9/l
1.7
1.8
0.54
170
1084
(3018010) Neutrophils/100 leukocytes in Blood
181
1151
2.24
11.84
6.6
5.1
%
58.6
57.7
0.48
168
1065
(42870588) Differential panel, method unspecified - Blood
139
794
2.28
11.81
6.8
5.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
179
1134
2.24
11.81
7.0
5.5
%
9.1
8.7
0.65
168
1048
(3002030) Lymphocytes/100 leukocytes in Blood
181
1152
2.24
11.80
6.9
5.4
%
26.2
27.2
0.50
167
1053
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
41
124
3.63
11.79
3.4
1.4
ug/l
22.4
4.9
0.76
33
96
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
176
1114
2.22
11.56
6.4
4.9
mmol/l
1.2
1.2
1.52
163
994
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
259
1932
2.49
11.31
9.9
5.3
u/l
82.3
75.8
1.22
243
1767
(3012095) Magnesium [Moles/volume] in Serum or Plasma
80
364
2.57
11.25
3.5
2.6
mmol/l
0.8
0.8
1.80
73
334
(3022096) Basophils/100 leukocytes in Blood
173
1097
2.19
11.20
6.9
5.2
%
0.7
0.7
0.10
163
1009
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
186
1222
2.17
10.90
7.4
5.6
mmol/l
1.2
1.2
0.50
161
1047
(40768795) Lymph node Pathology biopsy report
14
6
24.25
10.32
1.4
1.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
167
1082
2.08
9.82
6.0
3.5
g/l
35.2
35.5
0.36
153
1004
(3045142) Bone marrow Pathology biopsy report
14
19
7.65
9.77
1.3
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
118
708
2.03
8.24
5.6
3.2
ph
7.4
7.4
0.01
19
107
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
117
3.02
7.35
1.1
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
67
354
2.11
6.43
1.9
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
12
22
5.62
6.33
1.3
1.1
mosm/kgh2o
291.4
275.6
1.55
12
13
(3003694) ABO and Rh group [Type] in Blood
99
616
1.86
5.91
1.3
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
146
1049
1.69
5.19
7.1
9.6
inr
1.3
1.3
0.25
40
286
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
9
10.23
5.05
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
94
2.79
5.04
1.2
1.3
g/l
2.7
3.1
1.48
20
72
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
37
3.90
4.86
1.9
1.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
98
2.68
4.67
1.2
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
98
2.68
4.67
1.2
1.3
g/l
3.4
3.9
1.12
19
70
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
206
2.07
4.08
1.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
94
640
1.65
3.91
4.4
3.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
15
6.13
3.84
1.6
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
143
1084
1.56
3.77
11.4
7.9
e9/l
0.0
0.0
0.61
117
892
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
45
253
1.90
3.60
1.2
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
34
173
2.07
3.59
1.3
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
289
2595
1.81
3.56
19.3
12.6
mg/l
25.9
22.9
0.87
241
1990
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
194
1.96
3.26
3.6
1.9
ml/min/173m2
61.4
63.4
0.10
15
77
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
18
73
2.55
3.18
1.5
1.3
—
1.1
—
0
11
(3013826) Glucose [Moles/volume] in Serum or Plasma
187
1540
1.48
3.14
4.9
4.1
mmol/l
6.7
6.8
0.42
180
1432
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
132
1022
1.48
2.99
2.4
2.3
nmol/l
81.9
76.4
1.20
120
897
(3023103) Potassium [Moles/volume] in Serum or Plasma
300
2759
1.82
2.93
20.8
15.3
mmol/l
3.9
4.0
1.96
295
2679
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
58
2.66
2.91
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
95
691
1.52
2.90
2.7
2.4
umol/l
339.8
7511.7
2.96
82
597
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
13
5.47
2.88
1.1
1.6
nmol/l
3.7
4.3
—
7
13
(3019550) Sodium [Moles/volume] in Serum or Plasma
299
2750
1.79
2.88
20.5
15.2
mmol/l
139.3
139.8
2.80
294
2670
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
14
5.08
2.74
1.4
1.4
ug/l
13.8
16.7
—
7
14
(3003396) Base excess in Arterial blood by calculation
48
300
1.70
2.72
5.1
5.8
mmol/l
0.8
1.5
0.49
36
231
(3000494) Fungus identified in Specimen by Culture
49
310
1.68
2.66
1.7
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
15
4.74
2.61
1.9
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
20
4.07
2.58
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
35
204
1.80
2.53
6.3
6.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
43
271
1.67
2.38
2.5
2.2
umol/l
6.7
6.8
0.03
43
232
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
5
8
6.32
2.38
3.0
1.4
u/l
25.6
25.8
—
5
8
(3017732) Neutrophils [#/volume] in Blood
31
178
1.82
2.36
2.3
2.8
e9/l
3.9
3.8
0.08
21
126
(3013707) Erythrocyte sedimentation rate by Westergren method
222
1945
1.42
2.35
4.4
4.2
mm/h
14.0
12.0
1.02
198
1776
(3020564) Creatinine [Moles/volume] in Serum or Plasma
300
2795
1.68
2.31
22.6
14.7
umol/l
79.4
79.6
0.03
300
2795
(3012441) Differential panel - Pleural fluid
7
18
3.95
2.26
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
73
2.25
2.25
1.8
2.6
u/ml
0.3
0.4
—
6
39
(3019225) pH of Specimen
39
244
1.68
2.22
3.5
3.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
39
244
1.68
2.22
5.6
6.4
g/l
118.6
123.9
0.91
39
235
(3004451) EKG impression Narrative
5
9
5.62
2.22
1.2
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
8
24
3.39
2.19
1.4
1.2
g/l
31.4
24.2
—
8
19
(36304419) Bacteria [Presence] in Urine
87
656
1.44
2.17
2.8
2.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
30
3.05
2.16
1.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
37
2.75
2.12
1.4
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
113
897
1.39
2.10
2.9
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
150
1.79
1.97
1.3
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
16
3.80
1.94
1.5
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
52
2.36
1.90
1.3
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
247
1.61
1.89
3.8
3.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
17
3.57
1.84
1.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
17
3.57
1.84
1.5
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
55
393
1.48
1.80
1.8
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
61
2.18
1.74
1.2
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
297
2799
1.53
1.71
12.9
8.9
u/l
25.6
26.3
0.23
283
2678
(3005719) IgG [Mass/volume] in Serum or Plasma
27
165
1.69
1.71
2.6
2.0
g/l
10.9
10.8
0.02
27
151
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
19
3.20
1.67
2.0
2.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
106
862
1.34
1.64
2.5
3.0
ng/l
1102.8
1496.1
0.95
91
724
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
266
2463
1.38
1.63
19.4
11.3
ml/min/173m2
80.2
78.0
1.13
238
1979
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
20
3.04
1.59
1.3
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
20
3.04
1.59
1.3
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
254
2339
1.35
1.58
20.9
13.7
%
38.5
39.9
1.52
181
1604
(3045414) Leukocytes [Presence] in Urine
19
107
1.82
1.58
2.0
1.7
—
—
—
0
0
(3020891) Body temperature
19
107
1.82
1.58
3.4
4.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
23
138
1.72
1.56
1.7
1.3
g/l
1.6
1.1
0.30
23
129
(3004789) Transferrin [Mass/volume] in Serum or Plasma
49
353
1.45
1.55
2.8
2.3
g/l
2.2
2.3
0.51
44
330
(3044889) 12 lead EKG panel
210
1888
1.30
1.52
3.9
4.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
107
881
1.31
1.51
4.1
3.4
e6/l
52.8
89.1
0.65
79
612
(46235355) HIV 1 and 2 tests - Meaningful Use set
47
338
1.45
1.51
1.3
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
93
751
1.33
1.50
3.5
2.9
e6/l
29.5
145.6
0.71
73
568
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
121
0.40
1.40
1.0
4.3
%
4.7
1.7
—
5
116
(3037756) Immunofixation for Serum or Plasma
9
41
2.23
1.38
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
97
1.79
1.37
1.6
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
66
513
1.36
1.37
2.6
2.2
e6/l
6.4
5.1
0.34
60
437
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
42
2.17
1.34
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
73
904
0.75
1.33
3.2
3.1
—
—
—
0
0
(4268621)
6
24
2.53
1.31
3.0
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
281
1.44
1.26
1.6
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
25
2.42
1.25
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
74
594
1.32
1.24
3.0
3.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
84
687
1.30
1.23
3.3
2.8
e6/l
0.4
0.5
0.18
68
495
(40768443) Skin Pathology biopsy report
16
94
1.74
1.19
1.2
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
303
2904
1.44
1.19
27.9
18.5
fl
90.9
91.2
0.46
298
2850
(3007461) Platelets [#/volume] in Blood
303
2904
1.44
1.19
27.9
18.5
e9/l
242.7
245.8
0.35
293
2827
(3026361) Erythrocytes [#/volume] in Blood
303
2906
1.43
1.16
27.9
18.5
e12/l
4.4
4.5
3.48
291
2815
(1616796) Gas panel - Central venous blood
8
39
2.08
1.16
4.6
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
79
646
1.29
1.16
2.0
2.1
mg/l
2.6
3.2
1.35
60
539
(3010813) Leukocytes [#/volume] in Blood
303
2907
1.43
1.15
27.9
18.5
e9/l
6.6
6.7
0.32
292
2819
(1002224) Polysomnography panel
5
113
0.43
1.15
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
34
463
0.70
1.14
1.3
1.3
iu/ml
12.8
44.1
—
10
147
(3026008) Bacteria identified in Urine by Culture
93
779
1.27
1.13
3.1
3.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
194
1766
1.23
1.10
4.8
4.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
89
1.72
1.09
1.8
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
52
406
1.33
1.06
3.1
2.6
e6/l
1.6
2.3
0.40
30
210
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
33
2.14
1.06
1.9
1.2
nmol/l
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
67
1.82
1.06
5.7
3.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
43
327
1.36
1.04
3.1
2.4
%
25.4
23.5
0.34
37
284
(3003327) Ova and parasites identified in Stool by Light microscopy
13
75
1.76
1.04
1.5
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
22
2.29
1.03
2.6
1.7
u/ml
2.7
171.1
—
5
22
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
34
2.08
1.03
1.1
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
32
232
1.42
1.02
2.6
2.6
e9/l
69.5
65.5
0.14
18
185
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
35
2.02
1.00
2.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
441
0.72
1.00
1.2
1.3
u/ml
19.8
16.1
0.09
11
161
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
174
0.56
0.99
1.1
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
61
1.83
0.99
2.2
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
286
2734
1.31
0.98
15.3
12.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
69
1.77
0.97
1.5
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
279
1.37
0.95
1.6
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
61
497
1.28
0.93
3.1
2.5
mosm/kgh2o
523.5
558.4
0.59
55
408
(3000093) Morphology [Interpretation] in Blood Narrative
6
28
2.16
0.92
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
28
2.16
0.92
1.3
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
29
2.09
0.89
1.0
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
29
2.09
0.89
2.2
2.3
—
572.8
—
0
6
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
29
2.09
0.89
1.7
2.8
pg
33.8
33.0
—
6
29
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
29
2.09
0.89
1.0
3.2
—
32.9
—
0
8
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
255
2414
1.23
0.89
5.1
4.6
mu/l
2.0
2.4
0.39
226
2187
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
212
1973
1.20
0.87
4.3
3.8
pmol/l
14.7
14.9
0.63
191
1779
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
6
31
1.95
0.85
1.2
1.1
—
4.2
—
0
13
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
31
1.95
0.85
1.2
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
32
1.89
0.82
1.0
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
39
306
1.31
0.79
3.2
2.2
%
1.9
1.7
0.46
33
276
(40760892) CBC W Ordered Manual Differential panel - Blood
62
517
1.24
0.79
5.4
4.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
34
1.78
0.76
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
156
1426
1.18
0.75
2.4
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
55
1.65
0.74
1.8
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
159
0.62
0.74
1.3
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
25
2.01
0.73
2.0
1.5
%
92.0
89.9
—
5
25
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
56
1.62
0.73
1.6
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
40
1.77
0.71
1.7
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
26
1.94
0.71
3.2
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
127
1.44
0.69
6.2
7.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
27
1.86
0.68
1.4
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
65
554
1.21
0.68
1.9
1.7
mg/l
1.8
1.1
0.49
52
433
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
5
95
0.52
0.67
1.2
1.6
—
163.3
—
0
6
(3037121) Protein [Mass/volume] in Urine
13
86
1.53
0.67
2.3
2.2
g/l
2.4
0.3
—
6
27
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
434
1.23
0.67
2.9
2.4
e6/l
1.0
1.2
0.22
31
237
(4010399)
25
189
1.35
0.66
1.4
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
55
463
1.22
0.65
1.4
1.3
g/l
2.3
2.6
0.62
36
256
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
43
354
1.25
0.63
6.1
6.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
120
1088
1.16
0.62
3.5
3.8
ng/l
210.4
70.2
0.35
85
788
(3022217) INR in Platelet poor plasma by Coagulation assay
46
382
1.24
0.62
21.0
23.6
inr
1.4
1.3
—
8
55
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
50
1.61
0.61
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
60
693
0.84
0.59
4.2
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
62
536
1.19
0.57
1.9
1.7
nmol/l
1084.9
1161.2
0.23
45
410
(3044927) Protein electrophoresis panel - Urine
6
36
1.68
0.57
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
36
1.68
0.57
6.0
2.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
159
1.34
0.57
6.4
4.0
%
0.0
0.0
—
5
31
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.56
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
38
1.59
0.54
1.8
1.6
—
—
—
0
0
(4094501)
11
74
1.50
0.54
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
203
0.73
0.53
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
83
1.46
0.52
2.1
1.7
—
—
—
0
0
(3000492) Spirometry study
27
216
1.27
0.51
1.9
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
65
1.40
0.51
2.6
2.1
mg/l
11.0
13.1
—
9
60
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
255
2634
0.87
0.49
4.4
4.7
mmol/l
4.6
4.6
0.06
228
2432
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
91
823
1.14
0.49
4.0
2.2
u/l
62.9
58.5
0.15
84
760
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
187
0.74
0.47
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
119
0.66
0.46
1.5
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
81
0.61
0.46
2.0
1.7
nmol/l
43.6
41.3
—
5
76
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
77
1.44
0.46
2.5
3.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
175
1.28
0.44
6.3
3.9
%
0.7
0.6
—
6
38
(3021440) Promyelocytes/100 leukocytes in Blood
21
166
1.28
0.44
6.4
4.0
%
0.2
0.0
—
6
34
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
51
1.38
0.44
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
254
2618
0.88
0.44
4.3
4.7
mmol/l
1.5
1.5
0.06
222
2407
(4306422)
5
32
1.57
0.42
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
70
1.44
0.42
2.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
4.6
4.1
umol/l
313.6
344.5
—
5
29
(3017569) Oxygen content in Arterial blood
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
61
1.32
0.40
2.8
2.5
%
94.4
89.4
—
8
55
(4027681)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3015736) pH of Urine
107
992
1.12
0.39
3.2
3.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
37
1.36
0.37
1.2
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
76
830
0.89
0.36
3.9
3.7
%
24.1
24.2
0.02
37
370
(3013512) EKG study
89
821
1.11
0.35
4.2
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
114
1066
1.11
0.35
3.1
2.6
ug/l
174.2
134.1
0.47
96
978
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
263
2694
0.89
0.35
4.8
5.3
mmol/l
2.6
2.7
0.33
228
2478
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
80
869
0.90
0.35
3.3
3.3
mg/l
78.9
201.5
0.56
54
549
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
155
0.77
0.34
2.3
2.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
93
1000
0.90
0.34
4.2
3.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
86
928
0.90
0.33
4.5
4.1
mg/mmol
13.3
8.1
0.33
57
582
(40768797) Stomach Pathology biopsy report
42
372
1.15
0.32
1.4
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
75
690
1.11
0.32
1.6
1.5
nmol/l
18.7
21.0
0.61
61
588
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
131
0.76
0.31
1.6
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
64
1.26
0.27
1.1
1.1
—
23.2
—
0
8
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
122
1158
1.08
0.27
2.3
2.0
pmol/l
96.1
94.8
0.10
66
606
(3035350) Ketones [Presence] in Urine by Test strip
133
1268
1.08
0.26
3.5
3.6
estimate
0.0
0.0
0.00
19
216
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
71
0.70
0.26
3.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
86
916
0.92
0.26
3.3
3.1
mmol/l
7.3
7.5
0.12
64
760
(3036489) Thrombin time
9
74
1.22
0.25
2.7
2.3
s
24.6
21.3
—
9
67
(3025941) Bacteria identified in Stool by Culture
11
137
0.80
0.25
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
175
1692
1.07
0.23
2.7
3.0
u/l
46.9
47.2
0.01
164
1572
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
19
162
1.18
0.23
3.9
3.8
mmol/l
1.3
2.1
0.34
12
121
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
153
1.19
0.23
1.6
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
153
1.19
0.23
3.9
3.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
144
1.19
0.22
1.6
2.3
%
1.2
1.2
0.06
17
144
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
41
1.22
0.22
1.0
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
188
0.84
0.22
1.7
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
42
1.19
0.21
3.2
2.9
e9/l
4.0
4.2
—
5
42
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
12
98
1.23
0.21
1.6
1.7
ug/l
1.4
1.9
0.22
12
86
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
10
0.00
0.21
0.0
7.6
—
27.3
—
0
10
(3009871) Measles virus Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
9.1
—
0
10
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
0.7
—
0
7
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
248
2527
0.93
0.21
3.9
4.2
mmol/l
1.2
1.3
1.36
212
2307
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
43
1.17
0.21
3.2
3.4
%
56.6
56.7
—
5
43
(3005322) IgE [Units/volume] in Serum or Plasma
11
134
0.81
0.21
1.2
1.3
u/ml
46.4
217.0
3.45
11
124
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
187
0.85
0.21
2.0
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
49
1.23
0.20
1.3
1.1
u/l
25.0
14.3
—
6
40
(3037522) Nuclear Ab [Titer] in Serum
37
337
1.11
0.20
1.2
1.3
titre
1024.0
470.9
—
10
88
(3019230) Fractional oxyhemoglobin in Venous blood
6
50
1.20
0.20
2.2
1.7
%
69.3
61.1
—
6
50
(40761535) Cells panel - Urine sediment
25
222
1.14
0.19
2.4
3.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
165
1.16
0.19
1.7
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
51
1.18
0.19
1.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
49
526
0.92
0.18
1.2
1.2
u/ml
7.4
1.9
—
8
124
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
66
0.75
0.17
1.2
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
92
1.20
0.16
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
171
0.87
0.15
1.5
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
87
0.80
0.14
4.6
3.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
56
592
0.94
0.14
1.7
1.8
pmol/l
414.9
24375423.7
0.80
40
480
(3022313) Gas panel - Capillary blood
15
131
1.15
0.14
4.0
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
294
0.91
0.14
1.7
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
148
0.87
0.12
1.4
3.0
mmol/l
25.0
25.2
0.10
13
143
(3022145) Colonoscopy Study observation
28
260
1.08
0.11
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
166
0.90
0.10
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
19
175
1.09
0.08
3.2
4.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
61
0.82
0.08
2.2
2.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
5
60
0.83
0.08
4.4
4.0
mg/l
36.4
27.5
—
5
38
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
64
1.10
0.08
1.4
1.1
—
1.1
—
0
5
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
71
0.84
0.07
1.5
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
70
0.85
0.07
1.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.8
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
57
551
1.04
0.07
4.4
3.8
ng/l
47.5
233.5
1.93
51
438
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
81
0.86
0.07
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
83
0.84
0.07
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
83
0.84
0.07
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
84
0.83
0.07
1.4
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
25
265
0.94
0.07
2.7
3.2
kpa
5.7
5.8
0.16
25
255
(3015171) Extractable nuclear Ab [Units/volume] in Serum
8
95
0.84
0.06
1.9
1.2
—
1.4
—
0
7
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
264
2621
1.03
0.06
4.3
4.8
mmol/l
6.0
6.0
0.53
234
2368
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
346
1.05
0.05
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
90
1.11
0.05
1.7
2.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
15
139
1.08
0.05
5.2
2.6
e6/l
0.7
0.2
0.63
15
133
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
103
1047
0.98
0.05
4.7
3.8
ug/l
2.1
1.9
0.21
88
923
(3022621) pH of Urine by Test strip
17
179
0.95
0.03
4.1
2.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
571
0.98
0.03
2.8
2.7
ug/l
0.7
0.7
0.34
38
373
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
108
0.92
0.03
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
70
710
0.98
0.02
1.6
1.7
mmol/l
1.2
1.4
1.64
57
585
(3008152) Bicarbonate [Moles/volume] in Arterial blood
19
182
1.05
0.02
5.8
6.1
mmol/l
24.8
24.3
0.40
19
171
(3029937) Albumin [Presence] in Urine by Test strip
69
681
1.02
0.02
3.8
3.8
estimate
0.0
0.0
0.50
19
210
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
12
127
0.94
0.01
4.2
3.3
mmol/l
23.8
24.5
0.36
12
114
(40761536) Microorganisms panel - Urine sediment
19
197
0.96
0.01
5.3
3.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
127
1278
0.99
0.01
5.3
5.0
estimate
0.0
0.0
0.50
19
214
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
36
353
1.02
0.01
4.2
4.9
%
35.4
32.4
0.84
23
229
(3009261) Glucose [Presence] in Urine by Test strip
129
1297
0.99
0.01
3.8
3.7
estimate
0.0
0.0
0.00
19
207
(3048689) Calprotectin [Mass/mass] in Stool
27
276
0.98
0.00
1.8
2.2
ug/g
70.9
127.9
1.83
18
209
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
31
308
1.01
0.00
1.6
1.4
—
—
—
0
0
(4034850)
10
103
0.97
0.00
5.4
8.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
23
225
1.02
0.00
1.7
2.7
kpa
4.6
4.5
0.02
23
213
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
251
2514
0.99
0.00
5.5
6.4
mmol/mol
39.4
40.5
1.18
223
2326
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
7.9
—
0.7
—
0
8
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
8.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
18.5
—
0
5
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
1.1
—
0
7
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
82
0.98
0.00
1.4
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
9.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
12.4
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
67
0.89
0.00
2.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.2
—
7.2
—
0
5
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
6.2
—
70.4
—
0
5
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
2.0
—
24.0
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
8.8
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
54.4
—
0
5
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
43.8
—
0
5
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
63
0.95
0.00
1.7
1.2
—
47.5
—
0
6
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
5
58
0.86
0.00
1.8
1.8
umol/l
28.0
33.0
—
5
48
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PAROTIDGLAND_EXALLC – Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).